Read More Pharma Industry News Eli Lilly commits $6.5bn to new Houston manufacturing site for small molecule APIs Eli Lilly invests $6.5B in a Houston API facility to scale orforglipron and small molecule drugs, creating 4,600+ jobs and reshaping U.S. pharma supply. bySoujanya RaviSeptember 23, 2025